-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-05-21
FACOX:NMF-FACOX (USD)
MUTUAL FUND | Others |
Last Closing
USD 13.71Change
-0.24 (-1.72)%Market Cap
N/AVolume
N/AAnalyst Target
N/A
N/A
Verdict
Values as of: 2025-05-21
MUTUAL FUND | Others |
Last Closing
USD 13.71Change
-0.24 (-1.72)%Market Cap
N/AVolume
N/AAnalyst Target
N/AN/A
Verdict
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
VRGWX | Vanguard Russell 1000 Growth I.. |
+2.14 (+0.27%) |
USD 26.28B |
XMDYX | Mid Cap SPDR 400 Trust Series .. |
-0.84 (-0.15%) |
USD 19.32B |
VRTIX | Vanguard Russell 2000 Index Fu.. |
-0.14 (-0.04%) |
USD 10.02B |
VRVIX | Vanguard Russell 1000 Value In.. |
-1.16 (-0.36%) |
USD 9.85B |
VRNIX | Vanguard Scottsdale Funds - Va.. |
-0.07 (-0.01%) |
USD 7.05B |
VRTTX | Vanguard Russell 3000 Index Fu.. |
-0.08 (-0.02%) |
USD 3.51B |
XAODX | Alpine Total Dynamic Dividend .. |
-0.12 (-1.27%) |
USD 2.09B |
XNUVX | Nuveen Municipal Value Fd Inc |
-0.03 (-0.34%) |
USD 2.06B |
VRTGX | Vanguard Russell 2000 Growth I.. |
+0.21 (+0.06%) |
USD 1.19B |
XJPCX | Nuveen Preferred Income Opport.. |
-0.01 (-0.13%) |
USD 0.99B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
ZUT:CA | BMO Equal Weight Utilitie.. | 7.30 % | 0.60 % |
-0.22 (-0.13%) |
CAD 0.57B |
CIF:CA | iShares Global Infrastruc.. | 5.32 % | 0.72 % |
-0.38 (-0.13%) |
CAD 0.60B |
CDIV:CA | Manulife Smart Dividend E.. | 4.26 % | 0.00 % |
-0.02 (-0.13%) |
CAD 0.64B |
FXM:CA | First Asset Morningstar C.. | 3.59 % | 0.67 % |
-0.05 (-0.13%) |
CAD 0.30B |
TLV:CA | Invesco S&P/TSX Composite.. | 2.27 % | 0.34 % |
+0.07 (+-0.13%) |
CAD 0.07B |
Market Performance vs. Industry/Classification (Others) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Trailing 12 Months | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Trailing 5 Years | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | N/A | N/A | N/A | N/A | N/A | ||
Risk Adjusted Return | N/A | N/A | N/A | N/A | N/A | ||
Market Capitalization | N/A | N/A | N/A | N/A | N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
There is nothing we particularly dislike